Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Syndax Pharmaceuticals (NASDAQ: SNDX) announced the granting of inducement awards to two new employees under its 2023 Inducement Plan. The awards consist of stock options to purchase up to 23,900 shares of common stock. The options have a four-year vesting schedule, with 25% vesting after one year and the remaining shares vesting monthly over the following 36 months at a rate of 1/48th per month, contingent on continued employment with Syndax.
Syndax Pharmaceuticals (NASDAQ: SNDX) ha annunciato l'assegnazione di premi di incentivazione a due nuovi dipendenti nell'ambito del suo Piano di Incentivazione 2023. I premi consistono in opzioni su azioni per l'acquisto di fino a 23.900 azioni ordinarie. Le opzioni hanno un programma di maturazione di quattro anni, con il 25% che matura dopo un anno e le azioni rimanenti che maturano mensilmente nei successivi 36 mesi a una tariffa di 1/48 al mese, a condizione del proseguimento dell'impiego con Syndax.
Syndax Pharmaceuticals (NASDAQ: SNDX) anunció la concesión de premios de inducción a dos nuevos empleados bajo su Plan de Inducción 2023. Los premios consisten en opciones sobre acciones para comprar hasta 23,900 acciones ordinarias. Las opciones tienen un calendario de adquisición de cuatro años, con un 25% que se adquiere después de un año y las acciones restantes adquiriéndose mensualmente durante los siguientes 36 meses a una tasa de 1/48 al mes, condicionado a la continuación del empleo con Syndax.
신닥스 제약 (NASDAQ: SNDX)는 2023 인센티브 플랜에 따라 두 명의 신규 직원에게 유인 상을 수여한다고 발표했습니다. 이 상은 최대 23,900주의 보통주를 구매할 수 있는 스톡 옵션으로 구성되어 있습니다. 이 옵션은 4년의 취득 일정이 있으며, 1년 후에 25%가 취득되고, 나머지 주식은 다음 36개월 동안 월 1/48의 비율로 매달 취득되며, 신닥스와의 지속적인 고용이 조건입니다.
Syndax Pharmaceuticals (NASDAQ: SNDX) a annoncé l'octroi de primes d'incitation à deux nouveaux employés dans le cadre de son Plan d'Incitation 2023. Les primes se composent d'options d'achat d'actions permettant d'acheter jusqu'à 23 900 actions ordinaires. Les options ont un calendrier d'acquisition de quatre ans, avec 25 % acquérant une maturité après un an et les actions restantes acquérant une maturité mensuellement au cours des 36 mois suivants à un taux de 1/48 par mois, contingent à la poursuite de l'emploi avec Syndax.
Syndax Pharmaceuticals (NASDAQ: SNDX) gab die Gewährung von Anreizprämien an zwei neue Mitarbeiter im Rahmen seines Anreizplans 2023 bekannt. Die Prämien bestehen aus Aktienoptionen zum Kauf von bis zu 23.900 Aktien des Stammkapitals. Die Optionen haben einen vierjährigen Vesting-Zeitplan, wobei 25 % nach einem Jahr entfallen und die verbleibenden Aktien in den folgenden 36 Monaten monatlich zu einem Satz von 1/48 pro Monat entfallen, vorausgesetzt, dass das Beschäftigungsverhältnis mit Syndax fortgesetzt wird.
- Stock-based compensation aligns employee interests with shareholders
- Potential shareholder dilution from 23,900 new shares
About Syndax
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Highlights of the Company's pipeline include Revuforj® (revumenib), an FDA-approved menin inhibitor, and Niktimvo™ (axatilimab-csfr), an FDA-approved monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. For more information, please visit www.syndax.com or follow the Company on X (formerly Twitter) and LinkedIn.
Syndax Contact
Sharon Klahre
Syndax Pharmaceuticals, Inc.
sklahre@syndax.com
Tel 781.684.9827
View original content:https://www.prnewswire.com/news-releases/syndax-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302316942.html
SOURCE Syndax Pharmaceuticals, Inc.
FAQ
How many shares were granted in Syndax Pharmaceuticals (SNDX) December 2024 inducement awards?
What is the vesting schedule for SNDX's December 2024 inducement stock options?
How many employees received SNDX inducement grants in December 2024?
